This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignee: The Schepens Eye Research Institute, Inc.. Active years: 2018-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018-2023
Title: Magali Saint-Geniez: Innovator in Ocular Research
Introduction
Magali Saint-Geniez is a prominent inventor based in Somerville, MA (US). She has made significant contributions to the field of ocular research, particularly in the area of anti-angiogenic agents. With a total of 3 patents to her name, her work is paving the way for advancements in treating ocular diseases.
Latest Patents
Among her latest patents is the innovative method titled "Endomucin inhibitor as an anti-angiogenic agent." This method focuses on reducing neovascularization in ocular tissue by utilizing an inhibitor of endomucin expression or activity. This groundbreaking approach has the potential to significantly impact the treatment of various eye conditions.
Career Highlights
Magali Saint-Geniez is affiliated with The Schepens Eye Research Institute, Inc., where she conducts her research. Her work is characterized by a commitment to understanding and addressing complex ocular issues through innovative solutions.
Collaborations
She collaborates with esteemed colleagues such as Patricia A D'Amore and Cindy Park-Windhol, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Magali Saint-Geniez is a trailblazer in ocular research, with her patents and collaborations highlighting her dedication to advancing medical science. Her contributions are vital in the ongoing fight against ocular diseases, and her work continues to inspire future innovations.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile